---
title: "Jiayou International appoints Zhou Lijun as Chief Financial Officer"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238233683.md"
description: "According to the Zhitong Finance APP, Jiayou International announced that the company's board of directors received the resignation letter from Chief Financial Officer Ms. Wu Caijing on April 30, 2025. Ms. Wu Caijing applied to resign from her position as Chief Financial Officer for personal reasons, and the resignation will take effect from the date it is delivered to the company's board of directors. The company's board of directors agreed to appoint Ms. Zhou Lijun as the Chief Financial Officer of the company"
datetime: "2025-04-30T08:49:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238233683.md)
  - [en](https://longbridge.com/en/news/238233683.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238233683.md)
generator: "portal-rs"
---

# Jiayou International appoints Zhou Lijun as Chief Financial Officer

According to the Zhitong Finance APP, Jiayou International (603871.SH) announced that the company's board of directors received the resignation letter from Ms. Wu Caijing, the Chief Financial Officer, on April 30, 2025. Ms. Wu Caijing applied to resign from her position as Chief Financial Officer for personal reasons, and the resignation will take effect from the date it is delivered to the company's board of directors. The company's board of directors agreed to appoint Ms. Zhou Lijun as the Chief Financial Officer

### Related Stocks

- [603871.CN](https://longbridge.com/en/quote/603871.CN.md)

## Related News & Research

- [Howard Lutnick: US Govt Not Want Apple to Buy Memory Chips from CN](https://longbridge.com/en/news/296041149.md)
- [Sinotrans schedules online briefing on 2026 interim results](https://longbridge.com/en/news/296213993.md)
- [NATO members discuss Strait of Hormuz options without alliance involvement](https://longbridge.com/en/news/296639044.md)
- [Dicot Pharma submits EU clinical trial application for LIB-01 phase 2b study](https://longbridge.com/en/news/296068059.md)
- [Genetix kicks off sickle cell disease awareness campaign](https://longbridge.com/en/news/296468544.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**